Virus News and Research

Latest Virus News and Research

Fasting blood glucose levels upon admission tied to COVID-19 prognosis, study finds

In the study, which appeared on the pre-print open-source medRxiv* server, the investigators aimed to determine the prognostic value of blood glucose in predicting outcomes in COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Sep 2020

Mental preparedness of nurses and nursing students in India for COVID-19

Researchers from Bengaluru, India, tried to assess the psychological preparedness of Indian nurses and nursing students in the face of the COVID-19 pandemic. The pandemic that has now affected over 33.27 million people worldwide seems to rage on unabated and is something that these healthcare workers have never faced before in their careers.

28 Sep 2020

SARS-CoV-2 re-infection is real but rare: Case study

Now, American researchers have looked at all reported cases of re-infection and the possible reasons behind them. Their study titled, “Re-infection with SARS-CoV-2 and Failure of Humoral Immunity: a case report,” is published online on the preprint server medRxiv in September 2020.

28 Sep 2020

Healthy vitamin D levels could reduce COVID-19 complications

Published in the journal PLOS ONE, the study investigates the link between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes and parameters of immune function and mortality due to COVID-19.

28 Sep 2020

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were today announced by the Access to COVID-19 Tools (ACT) Accelerator.

28 Sep 2020

One-third of parents in the U.S. won’t get flu shots for their kids during the pandemic

A survey from the National Poll on Children’s Health, however, revealed that one-third of American parents have no plans of getting their children vaccinated for the flu virus this year during the COVID-19 pandemic.

28 Sep 2020

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

A multicenter phase 1/2a randomized, double-blinded, placebo-controlled clinical trial has been conducted recently to evaluate the safety, reactogenicity, and immunogenicity of a non-replicating adenovirus-based vaccine, namely Ad26.COV2.S against severe acute respiratory coronavirus 2 (SARS-CoV-2) infection.

28 Sep 2020

Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days

A recent study by French researchers has demonstrated that experimental exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) is capable of inducing mild infection in hamsters and ferrets within 7 – 10 days of exposure. However, the infection completely resolves within 14 days. The study is currently available on the bioRxiv preprint server.

28 Sep 2020

Resveratrol and pterostilbene inhibit SARS-CoV-2 infection in vitro

A team of scientists at the University of Groningen, in the Netherlands, demonstrates that a natural plant product, resveratrol, and its structural analog, pterostilbene, have long-lasting antiviral effects against severe acute respiratory coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the bioRxiv preprint server.

28 Sep 2020

Life-threatening COVID-19 associated with specific genetic variants

Results of a genome-wide association study on 2,244 critically-ill patients due to coronavirus disease (COVID-19) from 208 intensive care units across the United Kingdom revealed significant host-specific genetic determinants that can predispose people to the severe form of the disease. The report is currently available on the medRxiv preprint server.

28 Sep 2020

Mapping the evolutionary profile of SARS-CoV-2 and COVID-19 using mutation order approach

Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.

28 Sep 2020

Researchers decipher how the immune system memorizes pathogens after an infection

The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen. Now, scientists at the University of Würzburg have deciphered new details of this process.

28 Sep 2020

Saliva tests could be an effective approach for detecting asymptomatic COVID-19

Testing self-collected saliva samples could offer an easy and effective mass testing approach for detecting asymptomatic COVID-19.

28 Sep 2020

Evaporation is critical for coronavirus transmission in colder months

Dr. Talib Dbouk and Professor Dimitris Drikakis speak to News-Medical about how evaporation is essential for coronavirus transmission in the winter.

28 Sep 2020

Genetic mutations hinder immune response in severe COVID-19

Now, a truly international team of nearly 140 researchers aimed to determine why some people develop severe illness when once infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.

28 Sep 2020

Auto-antibodies may explain why some people develop severe COVID-19

Now, a new study by an international team of health experts shows that some life-threatening cases of COVID-19 can be traced to specific weak spots in the patients' immune system.

28 Sep 2020

Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys

The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the preprint server bioRxiv.

28 Sep 2020

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureus pneumonia and inflammatory lung damage.

28 Sep 2020

Seniors the optimal target for SARS-CoV-2 vaccination

ith several vaccines already in stage 3 clinical trials, a study by University of Warwick researchers and published on the preprint server medRxiv in September 2020 discusses the use of computer modeling techniques in order to achieve optimal vaccine coverage.

28 Sep 2020

People who had friendly interactions with Chinese people are less likely to support discriminatory policies

People with a history of positive social interactions with Chinese people were less likely to support discriminatory anti-Chinese policies as Covid-19 reached the UK - according to new research from the University of East Anglia.

28 Sep 2020

Virus News and Research

Latest Virus News and Research

Fasting blood glucose levels upon admission tied to COVID-19 prognosis, study finds

Mental preparedness of nurses and nursing students in India for COVID-19

SARS-CoV-2 re-infection is real but rare: Case study

Healthy vitamin D levels could reduce COVID-19 complications

New agreements to ensure all countries have fair access to COVID-19 rapid diagnostic tests

One-third of parents in the U.S. won’t get flu shots for their kids during the pandemic

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days

Resveratrol and pterostilbene inhibit SARS-CoV-2 infection in vitro

Life-threatening COVID-19 associated with specific genetic variants

Mapping the evolutionary profile of SARS-CoV-2 and COVID-19 using mutation order approach

Researchers decipher how the immune system memorizes pathogens after an infection

Saliva tests could be an effective approach for detecting asymptomatic COVID-19

Evaporation is critical for coronavirus transmission in colder months

Genetic mutations hinder immune response in severe COVID-19

Auto-antibodies may explain why some people develop severe COVID-19

Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Seniors the optimal target for SARS-CoV-2 vaccination

People who had friendly interactions with Chinese people are less likely to support discriminatory policies

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in